Phibro Animal Health Corporation $PAHC Shares Sold by State of Wyoming

State of Wyoming reduced its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 81.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,656 shares of the company’s stock after selling 11,504 shares during the period. State of Wyoming’s holdings in Phibro Animal Health were worth $57,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of PAHC. Trexquant Investment LP acquired a new position in Phibro Animal Health in the 1st quarter valued at $385,000. Brant Point Investment Management LLC acquired a new position in Phibro Animal Health in the 1st quarter valued at $2,216,000. Virtus Advisers LLC acquired a new position in Phibro Animal Health in the 1st quarter valued at $1,166,000. Quantbot Technologies LP grew its stake in shares of Phibro Animal Health by 53.8% during the 1st quarter. Quantbot Technologies LP now owns 7,870 shares of the company’s stock valued at $168,000 after buying an additional 2,754 shares during the period. Finally, Algert Global LLC grew its stake in shares of Phibro Animal Health by 1.4% during the 1st quarter. Algert Global LLC now owns 97,612 shares of the company’s stock valued at $2,085,000 after buying an additional 1,340 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PAHC has been the subject of a number of research reports. BNP Paribas Exane raised shares of Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price target for the company in a research report on Monday, June 16th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $25.00 to $35.00 in a research report on Monday, July 7th. Bank of America upped their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research report on Friday, August 29th. Morgan Stanley set a $34.00 price target on shares of Phibro Animal Health in a research report on Thursday, August 28th. Finally, Zacks Research cut shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 28th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $28.40.

Phibro Animal Health Stock Performance

Shares of Phibro Animal Health stock opened at $41.23 on Wednesday. The firm has a market cap of $1.67 billion, a PE ratio of 34.94, a price-to-earnings-growth ratio of 1.18 and a beta of 0.89. The firm’s 50-day simple moving average is $31.22 and its 200-day simple moving average is $25.14. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.25 and a current ratio of 2.76. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $41.39.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.05. The business had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. Equities analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health’s dividend payout ratio is 40.68%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.